ACURA PHARMACEUTICALS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) (audited) (audited) December 31, December 31, 2012 2011 ------------- -------------Current assets $ 27,991 $ 36,129Property, plant and equipment, net 1,052 1,044Other assets 11 - ------------- ------------- Total assets $ 29,054 $ 37,173 ------------- -------------Current liabilities $ 1,419 $ 530Other liabilities 5 -Stockholders' equity 27,630 36,643 ------------- ------------- Total liabilities and stockholders' equity $ 29,054 $ 37,173 ------------- ------------- ACURA PHARMACEUTICALS, INC. CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (in thousands, except per share data) (audited) (unaudited) Twelve Months Ended Three Months Ended December 31, December 31, 2012 2011 2012 2011 --------- --------- --------- ---------Revenues: Program fee revenue $ - $ 466 $ - $ - Milestone revenue - 20,000 - - --------- --------- --------- --------- Total revenues - 20,466 - - --------- --------- --------- ---------Operating expenses: Research and development 3,726 4,037 1,208 792 Selling, general and administrative 6,013 5,895 1,849 1,055 --------- --------- --------- --------- Total operating expenses 9,739 9,932 3,057 1,847 --------- --------- --------- --------- Operating income (loss) (9,739) 10,534 (3,057) (1,847)Non-operating income (expense): Interest income 79 32 48 10 Other expense, net (8) (34) (7) (3) --------- --------- --------- --------- Total other income (expense), net 71 (2) 41 7 --------- --------- --------- --------- Income (loss) before income taxes (9,668) 10,532 (3,016) (1,840) Provision (benefit) for income taxes - 147 - (194) --------- --------- --------- --------- Net income (loss) $ (9,668) $ 10,385 $ (3,016) $ (1,646) --------- --------- --------- ---------Other comprehensive income (loss), net of tax: Unrealized gains (losses) on securities (40) - - - --------- --------- --------- --------- Total other comprehensive income (loss) (40) - - - --------- --------- --------- --------- Comprehensive income (loss) $ (9,708) $ 10,385 $ (3,016) $ (1,646) --------- --------- --------- --------- --------- --------- --------- ---------Earnings (loss) per share: Basic $ (0.20) $ 0.22 $ (0.06) $ (0.03) Diluted $ (0.20) $ 0.22 $ (0.06) $ (0.03) --------- --------- --------- ---------Weighted average shares outstanding: Basic 47,521 47,496 47,523 47,806 Diluted 47,521 48,007 47,523 47,806 --------- --------- --------- ---------
Contact:
for Acura Investor Relations
Email Contact
847-705-7709
for Acura Media Relations
Email Contact
847-705-7709
